Navigate ICD-10-CM code updates for hematological disorders

Why This Topic Matters

These annual ICD-10-CM changes affect how common and complex hematological and immune-related diagnoses are reported in clinical records and claims. Understanding the scope of the update helps coding professionals stay current with revised diagnostic categories and related documentation needs.

Article Sections

1. Overview of 2021 ICD-10-CM chapter 3 updates

   Introduces the scope of the 2021 ICD-10-CM changes affecting blood, blood-forming organ, and immune-related disorders. Summarizes the major condition groups covered in the article.

2. Sickle-cell diseases

   Reviews the sickle-cell disease portion of the update, including hereditary background, clinical context, and the broader set of new diagnostic categories discussed in this section.

3. Sickle-cell thalassemia

   Covers the sickle-cell thalassemia updates and related disease subtypes included in the 2021 ICD-10-CM revision. Provides background on how this group is discussed in the article.

4. Autoimmune hemolytic anemia

   Summarizes the hemolytic anemia updates and the autoimmune forms addressed in the article. Includes general clinical and coding context for the revised category.

5. Immunodeficiency disorders

   Describes the update affecting immunodeficiency-related diagnoses and the distinction between broad disorder groupings discussed by the source. Notes the general clinical context for these changes.

6. CRS

   Covers cytokine release syndrome and the 2021 ICD-10-CM grading-related additions. Also summarizes the clinical context and consensus grading framework referenced by the article.

7. Other hematological disorders

   Reviews additional hematology-related updates, including eosinophilia and hypereosinophilic syndromes. Provides a broad overview of the remaining code changes noted in the article.